Sonendo Q3 revenue $9.8M (+25% YoY); net loss $15.5M; FY22 revenue guidance $40.5-42.5M

Sonendo, Inc.

2022-Q3 EPS reported -$1.61 revenue$29,426,000

Total revenue $9.8M, up 25% from $7.9M in Q3 2021; procedure instrument revenue $4.8M (+30% YoY).
GAAP net loss $15.5M vs $12.7M in prior year; non-GAAP loss from operations $12.4M vs $10.0M.
GentleWave install base reached ~935 units; gross margin 24% vs 26% a year ago.
Cash and short-term investments $105.6M; long-term borrowings $40.0M; completed $63M private financing.
Full-year 2022 revenue expected $40.5M–$42.5M, representing 22%–28% annual growth.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sonendo, Inc. reported third quarter ended September 30, 2022 results: revenue $9.8 million, net income $15.5 million net loss. Guidance reaffirmed.

Period: third quarter ended September 30, 2022
Revenue: $9.8 million
Net income: $15.5 million net loss
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total revenue was $9.8 million in the third quarter of 2022, an increase from $7.9 million in the third quarter of 2021.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sonendo, Inc. reported full year 2022 results: revenue $40.5 million to $42.5 million. Guidance reaffirmed.

Period: full year 2022
Revenue: $40.5 million to $42.5 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The Company expects full year 2022 total revenue to be in the range of $40.5 million to $42.5 million, representing annual growth between 22% and 28%.

View on SEC.gov

Browse all earnings releases →

Sonendo, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-22-023852

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.